← Back to Search

Procedure

AliveCor ECG Devices for Arrhythmia

N/A

Waitlist Available

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 seconds

Awards & highlights

Study Summary

This trial will assess the accuracy of two new AliveCor ECG devices, Kardia 12L and 6L, compared to standard 12-lead ECG recordings.

Who is the study for?

This trial is for men and women aged 18 or older who can sit still for an ECG and AliveCor Kardia recordings for 20 minutes. It's not suitable for those with internal stimulators, open chest wounds, recent chest surgery, or missing limbs affecting lead set-up.Check my eligibility

What is being tested?

The study tests the accuracy of two new ECG devices by AliveCor: Kardia 12L and Kardia 6L. These will be compared to standard ECGs to see how well they measure heart activity using statistical analysis methods.See study design

What are the potential side effects?

Since this trial involves non-invasive ECG recording, significant side effects are not expected. However, some individuals might experience minor discomfort from sitting still during the test.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 seconds

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 seconds

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 seconds for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Agreement on PR interval between Kardia 12L and ECG

Agreement on QRS width between Kardia 12L and ECG

Agreement on QT interval between Kardia 12L and ECG

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,392 Total Patients Enrolled

3 Trials studying Arrhythmia

2,649 Patients Enrolled for Arrhythmia

Stavros Stavrakis, MD, PhDStudy DirectorUniversity of Oklahoma

4 Previous Clinical Trials

608 Total Patients Enrolled

1 Trials studying Arrhythmia

200 Patients Enrolled for Arrhythmia

Media Library

Clinical Validation of the AliveCor Kardia 12L and 6L Devices (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05053243 — N/A

Arrhythmia Clinical Trial 2023: Clinical Validation of the AliveCor Kardia 12L and 6L Devices Highlights & Side Effects. Trial Name: NCT05053243 — N/A

Clinical Validation of the AliveCor Kardia 12L and 6L Devices (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05053243 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the eligibility criteria for individuals seeking to enroll in this investigation?

"Patients must have arrhythmia, cardiac issues and between 18 to 90 years old to be eligible for this medical trial. The desired patient pool is approximately 100 people strong in total."

Answered by AI

Does this clinical trial accept participants who are above the age of fifty?

"The age range for participants in this trial is 18 to 90. For minors, there are 8 separate studies and 70 further research projects available for those over 65 years old."

Answered by AI

Does this clinical investigation still have available slots for enrollment?

"The information published on clinicaltrials.gov indicates that this trial is not currently enrolling participants, despite being initially posted on the 27th of September 2021 and last edited on the 7th of November 2022. Though inactive as of now, there are 79 other studies actively admitting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Validation of the AliveCor Kardia 12L and 6L Devices

2021. "Clinical Validation of the AliveCor Kardia 12L and 6L Devices". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05053243.